Survey found that 51% of patients have concerns about in-office visits and nearly all sites have enacted additional protocols to ensure their continued health and safety
Company’s StudyTeam platform harmonizes biopharma and research site workflows, introducing a new paradigm for clinical research that brings therapies to patients sooner
